• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

荧光药物细胞药代动力学的流式细胞术评估

Flow cytometric assessment of the cellular pharmacokinetics of fluorescent drugs.

作者信息

Dordal M S, Ho A C, Jackson-Stone M, Fu Y F, Goolsby C L, Winter J N

机构信息

Clinical Pharmacology Center, Robert H. Lurie Cancer Center, Northwestern Memorial Hospital, Chicago, Illinois, USA.

出版信息

Cytometry. 1995 Aug 1;20(4):307-14. doi: 10.1002/cyto.990200406.

DOI:10.1002/cyto.990200406
PMID:7587718
Abstract

Development of multidrug resistance (MDR) in cancer cells decrease net doxorubicin uptake as a result of either increased efflux, or decreased intracellular sequestration, or decreased membrane permeability. Kinetic parameters of drug uptake can distinguish among these forms of altered transport. Cellular uptake of fluorescent drugs was monitored by a flow cytometric assay using a rapid-injection system and analyzed with a three-compartment model in which rapid diffusion from extracellular fluid into the cell was followed by uptake into a nonexchangeable pool. In agreement with our recent studies of 14C-doxorubicin distribution (Dordal et al.: J Pharmacol Exp Ther 271:1286-1290, 1994), sequestration of doxorubicin was decreased 2.7-fold in P-glycoprotein-expressing SU-4R lymphoma cells compared to drug-sensitive SU-4 cells (14.0 +/- 4.8 vs. 5.0 +/- 0.9 nl s-1) without a change in membrane permeability or evidence of active efflux. In contrast, sequestration of the highly fluorescent dye rhodamine 123 was decreased 20-fold (17.1 +/- 8.3 vs. 0.9 +/- 0.8 nl s-1). Resistant cells were significantly less permeable to rhodamine than sensitive cells (3.8 +/- 1.2 vs. 10.2 +/- 2.6 x 10(5) cm2 s-1), and rhodamine efflux was increased by 24%. Thus, SU-4R cells exhibit multiple alterations that cause decreased intracellular drug concentrations, of which decreased sequestration is quantitatively the most significant.

摘要

癌细胞中多药耐药性(MDR)的产生会导致阿霉素净摄取量减少,这是由于外排增加、细胞内隔离减少或膜通透性降低所致。药物摄取的动力学参数可以区分这些转运改变的形式。使用快速注射系统通过流式细胞术检测荧光药物的细胞摄取,并采用三室模型进行分析,该模型中,药物从细胞外液快速扩散进入细胞后,被摄取到一个不可交换的池。与我们最近对14C-阿霉素分布的研究结果一致(Dordal等人:《药理学与实验治疗学杂志》271:1286 - 1290,1994),与药物敏感的SU - 4细胞相比,表达P - 糖蛋白的SU - 4R淋巴瘤细胞中阿霉素的隔离减少了2.7倍(14.0 +/- 4.8对5.0 +/- 0.9 nl s-1),膜通透性没有变化,也没有主动外排的证据。相比之下,高荧光染料罗丹明123的隔离减少了20倍(17.1 +/- 8.3对0.9 +/- 0.8 nl s-1)。耐药细胞对罗丹明的通透性明显低于敏感细胞(3.8 +/- 1.2对10.2 +/- 2.6 x 10(5) cm2 s-1),罗丹明外排增加了24%。因此,SU - 4R细胞表现出多种导致细胞内药物浓度降低的改变,其中隔离减少在数量上最为显著。

相似文献

1
Flow cytometric assessment of the cellular pharmacokinetics of fluorescent drugs.荧光药物细胞药代动力学的流式细胞术评估
Cytometry. 1995 Aug 1;20(4):307-14. doi: 10.1002/cyto.990200406.
2
DiOC2(3) is not a substrate for multidrug resistance protein (MRP)-mediated drug efflux.DiOC2(3)不是多药耐药蛋白(MRP)介导的药物外排的底物。
Cytometry. 1996 Sep 1;25(1):14-20. doi: 10.1002/(SICI)1097-0320(19960901)25:1<14::AID-CYTO2>3.0.CO;2-E.
3
Decreased intracellular compartmentalization of doxorubicin in cell lines expressing P-glycoprotein.在表达P-糖蛋白的细胞系中,阿霉素的细胞内区室化减少。
J Pharmacol Exp Ther. 1994 Dec;271(3):1286-90.
4
Rhodamine 123: is it an appropriate dye to study P-glycoprotein activity in adriamycin-resistant K562 cells?罗丹明123:它是研究阿霉素耐药K562细胞中P-糖蛋白活性的合适染料吗?
Anticancer Res. 1995 Jan-Feb;15(1):121-6.
5
Dyes providing increased sensitivity in flow-cytometric dye-efflux assays for multidrug resistance.在多药耐药性的流式细胞术染料外排测定中提供更高灵敏度的染料。
Cytometry. 1995 Jul 1;20(3):218-27. doi: 10.1002/cyto.990200305.
6
Relation among the resistance factor, kinetics of uptake, and kinetics of the P-glycoprotein-mediated efflux of doxorubicin, daunorubicin, 8-(S)-fluoroidarubicin, and idarubicin in multidrug-resistant K562 cells.多药耐药K562细胞中阿霉素、柔红霉素、8-(S)-氟阿霉素和伊达比星的耐药因子、摄取动力学及P-糖蛋白介导的外排动力学之间的关系。
Mol Pharmacol. 1996 Mar;49(3):532-9.
7
Rhodamine efflux patterns predict P-glycoprotein substrates in the National Cancer Institute drug screen.罗丹明外排模式可预测美国国立癌症研究所药物筛选中的P-糖蛋白底物。
Mol Pharmacol. 1994 Oct;46(4):627-38.
8
Anti-CD19 antibodies inhibit the function of the P-gp pump in multidrug-resistant B lymphoma cells.抗CD19抗体可抑制多药耐药B淋巴瘤细胞中P-糖蛋白泵的功能。
Clin Cancer Res. 1999 Dec;5(12):3920-7.
9
Reduced drug resistance in a multidrug resistant cell line by 5,8,11,14-eicosatetraynoic acid.
Res Commun Mol Pathol Pharmacol. 1994 Nov;86(2):195-203.
10
Reversal effect of isotetrandrine, an isoquinoline alkaloid extracted from Caulis Mahoniae, on P-glycoprotein-mediated doxorubicin-resistance in human breast cancer (MCF-7/DOX) cells.从十大功劳茎中提取的异喹啉生物碱异粉防己碱对人乳腺癌(MCF-7/DOX)细胞中P-糖蛋白介导的阿霉素耐药性的逆转作用。
Yao Xue Xue Bao. 2008 May;43(5):461-6.

引用本文的文献

1
Doxorubicin and Aclarubicin: Shuffling Anthracycline Glycans for Improved Anticancer Agents.多柔比星和阿克拉霉素: shuffling 蒽环糖苷以改善抗癌药物。
J Med Chem. 2020 Nov 12;63(21):12814-12829. doi: 10.1021/acs.jmedchem.0c01191. Epub 2020 Oct 16.
2
Targeted Yttrium 89-Doxorubicin Drug-Eluting Bead-A Safety and Feasibility Pilot Study in a Rabbit Liver Cancer Model.靶向钇89-阿霉素药物洗脱微球——兔肝癌模型的安全性和可行性初步研究
Mol Pharm. 2017 Aug 7;14(8):2824-2830. doi: 10.1021/acs.molpharmaceut.7b00336. Epub 2017 Jul 25.
3
SW43-DOX ± loading onto drug-eluting bead, a potential new targeted drug delivery platform for systemic and locoregional cancer treatment - An in vitro evaluation.
SW43-DOX ± 负载于药物洗脱微球上,一种用于全身和局部区域癌症治疗的潜在新型靶向给药平台——体外评估
Mol Oncol. 2016 Aug;10(7):1133-45. doi: 10.1016/j.molonc.2016.05.003. Epub 2016 May 21.
4
The use of fluorescently-tagged apoptolidins in cellular uptake and response studies.荧光标记的凋亡诱导素在细胞摄取和反应研究中的应用。
J Antibiot (Tokyo). 2016 Apr;69(4):327-30. doi: 10.1038/ja.2016.22. Epub 2016 Mar 9.
5
Mathematical and computational models of drug transport in tumours.肿瘤药物传输的数学和计算模型。
J R Soc Interface. 2014 Mar 12;11(94):20131173. doi: 10.1098/rsif.2013.1173. Print 2014 May 6.
6
Predicting drug pharmacokinetics and effect in vascularized tumors using computer simulation.使用计算机模拟预测血管化肿瘤中的药物药代动力学和效果。
J Math Biol. 2009 Apr;58(4-5):485-510. doi: 10.1007/s00285-008-0214-y. Epub 2008 Sep 10.
7
Fluorescent CXCR4 chemokine receptor antagonists: metal activated binding.荧光CXCR4趋化因子受体拮抗剂:金属激活结合
Chem Commun (Camb). 2007 Jan 28(4):416-8. doi: 10.1039/b614557d. Epub 2006 Dec 4.
8
P-glycoprotein induction and tumor cell-kill dynamics in response to differential doxorubicin dosing strategies: a theoretical pharmacodynamic model.多柔比星不同给药策略下P-糖蛋白诱导及肿瘤细胞杀伤动力学:一个理论药效学模型
Pharm Res. 2005 May;22(5):710-5. doi: 10.1007/s11095-005-2585-8. Epub 2005 May 17.
9
Flow cytometry applications in pharmacodynamics and drug delivery.流式细胞术在药效学和药物递送中的应用。
Pharm Res. 1997 Sep;14(9):1106-14. doi: 10.1023/a:1012178001348.